Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PD-1H (VISTA)–mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus
Xue Han, Matthew D. Vesely, Wendy Yang, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 522
Closed Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

Longer-term (≥ 2 years) survival in patients with glioblastoma in population-based studies pre- and post-2005: a systematic review and meta-analysis
Michael T. C. Poon, Cathie Sudlow, Jonine D. Figueroa, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 245
VISTA: A Mediator of Quiescence and a Promising Target in Cancer Immunotherapy
Long Yuan, Jahnavi Tatineni, Kathleen M. Mahoney, et al.
Trends in Immunology (2021) Vol. 42, Iss. 3, pp. 209-227
Open Access | Times Cited: 159
The B7:CD28 family and friends: Unraveling coinhibitory interactions
Kelly P. Burke, Apoorvi Chaudhri, Gordon J. Freeman, et al.
Immunity (2024) Vol. 57, Iss. 2, pp. 223-244
Open Access | Times Cited: 32
Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities
Nanhao Yin, Xintong Li, Xuanwei Zhang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 20
VISTA: Coming of age as a multi-lineage immune checkpoint
Mohamed ElTanbouly, Evelien Schaafsma, Randolph J. Noelle, et al.
Clinical & Experimental Immunology (2020) Vol. 200, Iss. 2, pp. 120-130
Open Access | Times Cited: 102
The importance of immune checkpoints in immune monitoring: A future paradigm shift in the treatment of cancer
Hajar Alemohammad, Basira Najafzadeh, Zahra Asadzadeh, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112516-112516
Open Access | Times Cited: 71
Dendritic cells in systemic lupus erythematosus: From pathogenesis to therapeutic applications
Juan Liu, Xiaomin Zhang, Xuetao Cao
Journal of Autoimmunity (2022) Vol. 132, pp. 102856-102856
Closed Access | Times Cited: 49
Emerging Trends in Immunotherapy for Cancer
Alok Mishra, Amjad Ali, Shubham Dutta, et al.
Diseases (2022) Vol. 10, Iss. 3, pp. 60-60
Open Access | Times Cited: 46
Rationally targeted anti-VISTA antibody that blockades the C-C’ loop region can reverse VISTA immune suppression and remodel the immune microenvironment to potently inhibit tumor growth in an Fc independent manner
Dipti Thakkar, Shalini Paliwal, Bhushan Dharmadhikari, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 2, pp. e003382-e003382
Open Access | Times Cited: 41
Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors
Dia Roy, Cassandra Gilmour, Sachin Patnaik, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27
VISTA and its ligands: the next generation of promising therapeutic targets in immunotherapy
Najibeh Shekari, Dariush Shanehbandi, Tohid Kazemi, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 26
Immunopathogenesis of systemic lupus erythematosus: An update
Laurent Arnaud, François Chasset, Thierry Martin
Autoimmunity Reviews (2024) Vol. 23, Iss. 10, pp. 103648-103648
Closed Access | Times Cited: 13
VISTA-induced tumor suppression by a four amino acid intracellular motif
Yan Zhao, T Andoh, Fatima Charles, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access | Times Cited: 1
Immune Checkpoint Agonists for Inflammatory Skin Diseases
Matthew D. Vesely, Paul F. Lizzul, Paul Klekotka, et al.
Journal of Investigative Dermatology (2025)
Closed Access | Times Cited: 1
Current Progress and Future Perspectives of Immune Checkpoint in Cancer and Infectious Diseases
Xin Cai, Huajie Zhan, Yuguang Ye, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 52
The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead
Negar Hosseinkhani, Afshin Derakhshani, Mahdi Abdoli Shadbad, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 49
Detection of Immune Checkpoint Receptors – A Current Challenge in Clinical Flow Cytometry
Benjamin Shibru, Katharina Fey, Stephan Fricke, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 44
Regulation of activated T cell survival in rheumatic autoimmune diseases
Florencia Rosetti, Iris K. Madera‐Salcedo, Noé Rodríguez‐Rodríguez, et al.
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 4, pp. 232-244
Closed Access | Times Cited: 37
Immune cellular components and signaling pathways in the tumor microenvironment
Sasitorn Yenyuwadee, Konstantinos Aliazis, Qi Wang, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 187-201
Open Access | Times Cited: 33
Expression and function of VISTA on myeloid cells
Siyu Li, Geng Wang, Yan Ren, et al.
Biochemical Pharmacology (2024) Vol. 222, pp. 116100-116100
Closed Access | Times Cited: 7
Single-cell RNA-Seq reveals the transcriptional landscape and heterogeneity of skin macrophages in Vsir-/- murine psoriasis
Chenxin Qie, Jingwei Jiang, Wanmei Liu, et al.
Theranostics (2020) Vol. 10, Iss. 23, pp. 10483-10497
Open Access | Times Cited: 48
A systematic review of pharmacological activities, toxicological mechanisms and pharmacokinetic studies on Aconitum alkaloids
Mi Li, Yuchen Li, Mengru Sun, et al.
Chinese Journal of Natural Medicines (2021) Vol. 19, Iss. 7, pp. 505-520
Closed Access | Times Cited: 39
VISTA: A Target to Manage the Innate Cytokine Storm
Mohamed ElTanbouly, Yanding Zhao, Evelien Schaafsma, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 37
VISTA immune regulatory effects in bypassing cancer immunotherapy: Updated
Keywan Mortezaee, Jamal Majidpoor, Sajad Najafi
Life Sciences (2022) Vol. 310, pp. 121083-121083
Closed Access | Times Cited: 26
Connecting the mechanisms of tumor sex differences with cancer therapy
Huan Li, Weibo Jiang, Shui Liu, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 2, pp. 213-231
Closed Access | Times Cited: 14
Page 1 - Next Page

Scroll to top